This is road map in Canada:
Key Milestones
Milestones title Date
Call for patient/clinician input open 16-Aug-24
Call for patient/clinician input closed 15-Oct-24
Submission received 29-Oct-24
Submission accepted 13-Nov-24
Review initiated 14-Nov-24
Draft Canada's Drug Agency review report(s) provided to sponsor for comment 05-Feb-25
Deadline for sponsors comments 14-Feb-25
Canada's Drug Agency review report(s) and responses to comments provided to sponsor 13-Mar-25
Expert committee meeting (initial) 26-Mar-25
Draft recommendation issued to sponsor April 07, 2025
To
April 09, 2025
Draft recommendation posted for stakeholder feedback 17-Apr-25
End of feedback period 05-May-25
https://www.cda-amc.ca/trofinetide
- Forums
- ASX - By Stock
- Ann: Trofinetide marketing application submitted in Europe
NEU
neuren pharmaceuticals limited
Add to My Watchlist
6.14%
!
$13.31

This is road map in Canada: Key Milestones Milestones title Date...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.31 |
Change
0.770(6.14%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $19.76M | 1.453M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | $13.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.33 | 3716 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 13.300 |
2 | 10200 | 13.200 |
1 | 2500 | 13.190 |
2 | 1750 | 13.180 |
1 | 50 | 13.170 |
Price($) | Vol. | No. |
---|---|---|
13.330 | 3716 | 1 |
13.370 | 3716 | 1 |
13.390 | 600 | 1 |
13.400 | 3783 | 2 |
13.430 | 3716 | 1 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online